Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Feinberg

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
AIDS Reviews|November 6, 2003
AIDS vaccine development: the long and winding roadDavid A Garber, Mark B Feinberg
Nature Medicine|March 5, 2002
AIDS vaccine models: challenging challenge virusesMark B Feinberg, John P Moore
Immunological Reviews|September 9, 2022
Introductory article for Immunological Reviews, Vol 310Dennis R Burton, Mark B Feinberg
BMC Immunology|April 17, 2008
Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivoLuzheng Liu, Rahul Chavan, Mark B Feinberg
The Lancet. Infectious Diseases|June 29, 2004
Prospects for an AIDS vaccine: three big questions, no easy answersDavid A Garber, Guido Silvestri, Mark B Feinberg
Journal of Virology|February 12, 2002
Contribution of peaks of virus load to simian immunodeficiency virus pathogenesisRoland R Regoes, Silvija I Staprans, Mark B Feinberg, et al.
Journal of the International AIDS Society|November 22, 2021
The importance of partnerships in accelerating HIV vaccine research and developmentMark B Feinberg, Nina D Russell, Robin J Shattock, et al.
Journal of Virology|August 19, 2007
Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escapeJudith N Mandl, Roland R Regoes, David A Garber, et al.
Plos Medicine|July 16, 2005
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challengesRoland R Regoes, Ira M Longini, Mark B Feinberg, et al.
Current Opinion in HIV and AIDS|October 28, 2010
Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspectiveSilvija I Staprans, Mark B Feinberg, John W Shiver, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
AIDS Reviews|November 6, 2003
AIDS vaccine development: the long and winding roadDavid A Garber, Mark B Feinberg
Nature Medicine|March 5, 2002
AIDS vaccine models: challenging challenge virusesMark B Feinberg, John P Moore
Immunological Reviews|September 9, 2022
Introductory article for Immunological Reviews, Vol 310Dennis R Burton, Mark B Feinberg
BMC Immunology|April 17, 2008
Dendritic cells are preferentially targeted among hematolymphocytes by Modified Vaccinia Virus Ankara and play a key role in the induction of virus-specific T cell responses in vivoLuzheng Liu, Rahul Chavan, Mark B Feinberg
The Lancet. Infectious Diseases|June 29, 2004
Prospects for an AIDS vaccine: three big questions, no easy answersDavid A Garber, Guido Silvestri, Mark B Feinberg
Journal of Virology|February 12, 2002
Contribution of peaks of virus load to simian immunodeficiency virus pathogenesisRoland R Regoes, Silvija I Staprans, Mark B Feinberg, et al.
Journal of the International AIDS Society|November 22, 2021
The importance of partnerships in accelerating HIV vaccine research and developmentMark B Feinberg, Nina D Russell, Robin J Shattock, et al.
Journal of Virology|August 19, 2007
Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escapeJudith N Mandl, Roland R Regoes, David A Garber, et al.
Plos Medicine|July 16, 2005
Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challengesRoland R Regoes, Ira M Longini, Mark B Feinberg, et al.
Current Opinion in HIV and AIDS|October 28, 2010
Role of nonhuman primates in the evaluation of candidate AIDS vaccines: an industry perspectiveSilvija I Staprans, Mark B Feinberg, John W Shiver, et al.
Pageof 6